Adrenal insufficiency: Still a cause of morbidity and death in childhood

Pediatrics

Volumn 119, Issue 2, 2007, Pages

  Shulman, Dorothy I ^a   Palmert, Mark R ^b   Kemp, Stephen F ^c  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

Adrenal disorders; Adverse outcomes; Morbidity mortality

Indexed keywords

ALDOSTERONE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISONE; SODIUM CHLORIDE;

ADRENAL INSUFFICIENCY; BLOOD PRESSURE; CHILDHOOD MORTALITY; CLINICAL FEATURE; DOSE RESPONSE; DRUG HALF LIFE; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HORMONE DEFICIENCY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LABORATORY TEST; MEDICAL EDUCATION; NEWBORN MORBIDITY; PRECIPITATION; PRIORITY JOURNAL; PROPHYLAXIS; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SUSTAINED RELEASE PREPARATION;

ADOLESCENT; ADRENAL INSUFFICIENCY; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INFANT;

EID: 33947170939     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1612     Document Type: Review

References (49)

1. Addison T. On the Constitutional and Local Effects of Disease of the Supra-renal Capsules. London, United Kingdom: Highley; 1855
2. Arlt W, Allollo B. Adrenal insufficiency. Lancet. 2003;361:1881-1893
3. Ten S, New M, MacLaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab. 2001;86:2909-2922
4. Simm PJ, McDonnell CM, Zacharin MR. Primary adrenal insufficiency in childhood and adolescence: advances in diagnosis and management. J Paediatr Child Health. 2004;40:596-599
5. Root AW, Shulman DI. Clinical adrenal disorders. In: Pescovitz OH, Eugster EA, eds. Pediatric Endocrinology, Mechanisms, Manifestations, and Management. Philadelphia, PA: Lippincott, Williams and Wilkins; 2004:568-600
6. Perry R, Kecha O, Paquette J, Huot C, Van Vliet G, Deal C. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab. 2005;90:3243-3250
7. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245-291
8. Kovacs J, Votava F, Heinze G, et al. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab. 2001;86:2958-2965
9. Swerdlow AJ, Higgins CD, Brook CG, et al. Mortality in patients with congenital adrenal hyperplasia: a cohort study. J Pediatr. 1998;133:516-520
10. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048-4053
11. Van Vliet G, Czernichow P. Screening for neonatal endocrinopathies: rationale, methods and results. Semin Neonatol. 2004;9:75-85
12. New MI, Carlson A, Obeid J, et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab. 2001;86:5651-5657
13. Felner EI, Thompson MT, Ratliff AF, White PC, Dickson BA. Time course of recovery of adrenal function in children treated for leukemia. J Pediatr. 2000;137:21-24
14. Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia, PA: Saunders; 2003:491-551
15. Walvoord EC, Rosenman MB, Eugster EA. Prevalence of adrenocorticotropin deficiency in children with idiopathic growth hormone deficiency. J Clin Endocrinol Metab. 2004;89:5030-5034
16. Buchanan CR, Preece MA, Milner RD. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ. 1991;302:824-828
17. Taback SP, Dean HJ. Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab. 1996;81:1693-1696
18. Mills JL, Schonberger LB, Wysowski DK, et al. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr. 2004;144:430-436
19. Todd GRG, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87:457-461
20. Dunlop KA, Carson DJ, Steen HJ, McGovern V, McNaboe J, Sheilds MD. Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression. Arch Dis Child. 2004;89:713-715
21. Wilson TA, Speiser P. Adrenal insufficiency. Available at: www.emedicine.com/PED/topic47.htm. Accessed April 30, 2006
22. Binder G, Bosk A, Gass M, Ranke MB, Heidemann PH. Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias. Horm Res. 2004;62:84-87
23. Bottner A, Kratzsch J, Liebermann S, et al. Comparison of adrenal function tests in children: the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children. J Pediatr Endocrinol Metab. 2005;18:433-442
24. Maghnie M, Uga E, Temporini F, et al. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol. 2005;152:735-741
25. Charmandari E, Kino T, Chrousos GP. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann N Y Acad Sci. 2004;1024:168-181
26. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab. 1993;76:1505-1510
27. Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F. Cortisol production rate in childhood and adolescence. J Pediatr. 1990;117:892-896
28. Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab. 1991;72:39-45
29. Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol. 2001;169:65-70
30. Weise M, Drinkard B, Mehlinger SL, et al. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab. 2004;89:3679-3684
31. Levine A, Cohen D, Zadik Z. Urinary free cortisol values in children under stress. J Pediatr. 1994;125:853-857
32. Shaikh MG, Lewis P, Kirk JM. Thyroxine unmasks Addison's disease. Acta Paediatr. 2004;93:1663-1665
33. Havard CW, Saldanha VF, Bird R, Gardner R. Adrenal function in hypothyroidism. Br Med J. 1970;1(5692):337-339
34. Giavoli C, Libe R, Corbetta S, et al. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab. 2004;89:5397-5401
35. Oberfield SE, Chin D, Uli N, David R, Sklar C. Endocrine late effects of childhood cancers. J Pediatr. 1997;131(1 pt 2):S37-S41
36. Bottner A, Keller E, Dratzsch J, Stobbe H, Weigel JF, Keller A. PROP 1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab. 2004;89:5256-5265
37. Benvenga S, Campenni A, Ruggeri RM, Trimarchi F. Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab. 2000;85:1353-1361
38. den Brinker M, Joosten KF, Liem O, et al. Adrenal insuffi-ciency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab. 2005;90:5110-5117
39. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-867
40. Pizarro CF, Torster EJ, Damiani D, Carcillo JA. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med. 2005;33:855-859
41. Cohan P, Wang C, McArthur DL, et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med. 2005;33:2358-2366
42. Hamrahian AH, Olsen TS, Arafat BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350:1629-1638
43. Huysman MW, Hokken-Koelega AC, De Ridder MA, Sauer PJ. Adrenal function in sick very preterm infants. Pediatr Res. 2000;48:629-638
44. Seri I, Evans J. Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr. 2001;13:116-123
45. Scott SM, Cimino DF. Evidence for developmental hypopituitarism in ill preterm infants. J Perinatol. 2004;24:429-434
46. Ng PC, Lee CH, Lam CWK, et al. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2004;89:F119-F126
47. Efird MM, Heerens AT, Gordon PV, Bose CL, Young DA. A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. J Perinatol. 2005;25:119-125
48. Ng PC, Lee CH, Bnur FL, et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics. 2006;117:367-375
49. Watterberg KL, Gerdes JS, Cole CH, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: multicenter trial. Pediatrics. 2004;114:1649-1657